Q&A

In this Q and A, Nader Shaik, MD, MPH, discusses the results of his team's recent study examining treatment failure rates of short-course vs standard-course antimicrobial therapy for the treatment of...

In this expert Q&A, Cécile Philippoteaux, MD, MSc, PharmD, discusses the results of her team’s recent review, including the prevalence, characteristics, definition, and the next steps for research in...

In this interview, Deya N. Jourdy, MD, talks about the clinical features, prevalence, diagnosis, and treatment for nasal polyps, including what surgical options are available for patients.

In this expert Q&A, Margaret A. Lampe, RN, MsC, discusses the elimination of perinatal HIV transmission, elimination goals set out by the CDC, next steps for research, and more.

In this Q&A, Brittany A. Davidson, MD, discusses navigating goals-of-care conversations in gynecologic oncology, including how to identify patients at high risk of death who might benefit from a timely...

In this interview, Elmar Joura, MD, answers questions about the long-term follow-up data on sustained immunogenicity and safety for the 9-valent human papillomavirus (HPV) vaccine, including indications,...

In this interview, Jacob C. Jentzer, MD, assistant professor of medicine in the Department of Cardiovascular Medicine at the Mayo Clinic in Rochester, Minnesota discusses the implications of his study and...

Stephanie Blank, MD, answers questions about the session she hosted at The Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women's Cancer titled “The Future is Now: Determining the Fate of...

Yuriko Fukuta, MD, PhD, discusses her research team's study, which evaluated the risk factors associated with post-COVID conditions. She presented her findings at IDWeek 2023 in Boston, MA.

Acetylcholinesterase inhibitors are frequently used in the treatment of Alzheimer disease due to their anti-inflammatory effects. But what is the potential of this class of medications to also impact the...